Genomic study sheds light on protective effects of malaria vaccine candidate

21 octubre 2015

An international team of researchers has used cutting edge genomic methods to uncover key biological insights that help explain the protective effects of the world’s most advanced malaria vaccine candidate, RTS,S/AS01 (RTS,S). Applying highly sensitive sequencing technology to more patient samples than previously tested, the team was able to determine that genetic variation in the protein targeted by RTS,S influences the vaccine’s ability to ward off malaria in young children.